Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
An account is an optional way to support the work we do. Find out more.
Sam Boal via RollingNews.ie
credit note
State guarantee given for refund credit notes issued by travel agents and tour operators
Tourism Minister Shane Ross received government approval for the proposals today.
6.35pm, 8 May 2020
33.5k
37
THE GOVERNMENT HAS confirmed it will provide a State guarantee for a special form of refund credit note for package holidays booked through Irish registered travel agents and tour operators.
Tourism Minister Shane Ross received government approval for the proposals today.
The credit notes can be offered by travel agents and tour operators to their customers in circumstances where they are not able to provide a cash refund or a full cash refund.
“The travel restrictions imposed across the world in response to the Covid-19 pandemic have led to the widespread cancellation of holidays during March, April and May, with many people having to postpone holiday, wedding and honeymoon plans,” Minister Ross said.
“Under the EU Travel Package Directive, people who have had to cancel such bookings because of Covid-19 travel are entitled to a cash refund, and that entitlement will continue,” he said.
However, it is also the case that many travel agents and tour operators are having severe cash flow problems, and it is not clear that all of them will be able to meet all of their current cash refund obligations and at the same time be able to stay in business.
“The government has therefore agreed to back a new refund credit note that travel agents and tour operators can offer to their customers.”
The refund notes will work as follows:
It can be to the value of all of the refund due or part of the refund alongside part cash
It will be redeemable for its cash value after six months and can be used to book a replacement holiday at any stage
It will be State-guaranteed in the event that the travel agent or tour operator becomes insolvent
Minister Ross said these are very difficult days for consumers who have booked holidays, for the tourism industry and for the many travel agents and tour operators who have seen their businesses face near-collapse in recent months.
Advertisement
He said the refund credit note is an attempt to strike a balance between preventing sector-wide bankruptcy and consumer rights.
EU letter
On 29 April, the government co-signed a letter with a number of EU countries asking for the European Commission to change the rules on how airline passengers can be refunded for cancelled flights.
The letter, which has been signed by 13 member states, calls for the commission to temporarily allow airlines to issue vouchers instead of refunds to passengers whose flights have been cancelled due to the Covid-19 pandemic.
Under EU Regulation 261/2014, airlines must reimburse passengers whose flights are cancelled the choice of a refund or a re-routing within seven days.
But the member states – Ireland, Belgium, Bulgaria, Cyprus, the Czech Republic, Greece, France, Latvia, Malta, the Netherlands, Poland and Portugal – said current rules place airlines in a difficult situation, particularly as many are facing financial difficulties.
The joint letter stated that the temporary use of vouchers would be acceptable for consumers if key principles, such as transparency, a common length of voucher validity, maximum flexibility of use and a right to reimbursement at the end of the validity period in the event of non-use, were adhered to.
The letter followed complaints from customers that Ryanair and Aer Lingus had joined a number of other airlines across the continent in primarily offering vouchers to those whose flights had been cancelled.
With reporting by Stephen McDermott
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
@Ian Moloney: why can’t they work? And how would that stop them paying tax? The unemployed are still expected to pay VAT and people are taxed when collecting job seekers or injury/illness benefit.
@Ian Moloney: I didn’t say it was, I’m just trying to correct you by explaining, in what I thought were simple terms, that unemployed people pay taxes too. I also pointed out that using medicinal cannabis wouldn’t preclude user from working. I would also hope bus drivers aren’t taking opioids while working.
Ian just because alcohol is lefal dies it mean everyonegoes to work drunk? No.
I know literally hundreds of people who work hard, are productive healthy members of society and in a lot of cases high achievers. Your preconceptions are misfounded and illinformed.
Ian the point I made is very relevant to the discussion. I framed it using the alcohol analogy because I felt it might help you to understand as you clearly have no idea what you are talking about regarding cannabis.
But you are very good at your spelling. Well done, gold star for you today.
Personally I can’t stomach the fake outbursts and cheap pr stunts staged by many far lefties but on this issue they have a point. The puritan like attitude of FG/FF/LAB etc on this issue is equally sickening.
This isn’t a left right issue its a common sense one. Right now you can get cannabis in any village in Ireland but god only knows the quality of how it is produced and processed. If politicians were concerned about public health they would legalize and regulate this herb.
Right about opioids. A family member has been put on oxycontin, the lowest dose at the moment to control pain from cancer. All of a sudden, symptoms which were never there before are appearing since starting the drug. I looked it up and common side effects are
constipation,
nausea,
stomach pain,
loss of appetite,
vomiting,
sleepiness,
tiredness,
drowsiness,
dizziness,
lightheadedness,
weakness,
itching,
headache,
dry mouth,
sweating
Would they ever hurry up and legalise medicinal cannabis.
Are you aware that nearly every drug has a list of horrible *potential* side effects?
A potential side effect of paracetamol is liver failure and death, would you call it unsafe?
Oxycodone is a useful analgesic when used properly, its main flaw being potential for addiction.
Cannabis (specifically THC) hasn’t been demonstrated by any scientific standard to be an effective analgesic, and certainly nowhere near the level needed for cancer pain.
Please, stay in the realm of facts if you want to defend the use of cannabis which certainly has medical uses.
@Malachi: I can tell you now that as soon as this drug was started, they were not potential side effects, she actuallyexperienced them. Nausea, vomiting, weakness, tiredness, loss of appetite appeared which were not there two days previous. The nurse handed us a prescription for two different constipation medicines. I ask her why. She said oxycontin causes constipation and she was right.
@watersedge: tell your family member to get tablets from the doctor that help to protect the stomach while she’s taking those God awful things. I can’t remember the name of the tablets I took but they were Proten or something like that. They definitely helped and she just has to eat before taking them, it makes all the difference.
@jane: Thanks. Pantoprazole is probably what you mean and she is on them plus trying her best to eat before taking them but still no joy. Too much of a coincidence that she is getting all these symptoms since starting the oxycontin even though the dose is the lowest. They are good for pain but I think they jumped in too quick prescribing them long term as it was an infection which caused the pain and it is cleared up now.
I sound like I am contradicting myself. They put her on them at the start as they thought is was a small lesion from the cancer pressing on a nerve but found out it was an infection. I’m not happy they have just decided to keep her on them now anyway in case she gets a pain in the future instead of waiting until she actually needs them and so she is stuck with all these side effects.
@watersedge: they really are awful. I would agree with you about not leaving her on them, she’ll start to get a resistance to them and then she’ll have to increase the dosage if she does have pain.
Malachi. The point is that the side effects of cannabis are not nearly as bad, as you rightly point out if not used correctly even paracetomal can kill. Wheras cannabis cannot.
So if it provides some sick people releif of any kind and is less harmful than most over the counter drugs, just let them have it, in a regulated monitored fashion..
so what if they also get a bit of a buzz from it, that is why most people are opposed to it, the buzz, nothing to do with safety really.
@john doe: “The point is that the side effects of cannabis are not nearly as bad, [...] paracetomal can kill. Wheras cannabis cannot.”
Cannabis use has side effects too, like any drug. It’s not going to kill you by overdose, but neither will smoking cigarettes – it’s long-term effects we’re dealing with here.
“if it provides some sick people releif of any kind and is less harmful than most over the counter drugs”
It does provide *some* sick people effective relief for their specific conditions – which is what the HPRA approved its use for in their report. What is the objection? We have no idea whether long term cannabis use is “less harmful” than ‘most OTC drugs’. Indeed, most OTC drugs have a great safety record when used properly.
“A legally protected, secure supply of a quality-controlled cannabis-based product, that is effective, and safer than many authorised products, especially for pain relief”. So that would be a synthetic substitute developed by the same companies who gave us Fentanyl then? The government should not be allowed to police the body politic of an adult individual of sound mind so they can monetize people like commodities for private exploitation. The pharmaceutical companies already play fast and loose with people’s lives and the government should protect us from exploitation, not direct us towards it. “We will support a health-led approach rather than a criminal justice approach to drug use.”, which is why the majority of drug busts in the headlines over the past few months have been cannabis seizures? No cannabis, no users, no problem. The drug war is a lie for corporate profit, people who are sick or have sick children should take whatever measures they can to treat the symptoms of that illness, as has proven to be the case with cannabis in many instances. The government aren’t going to help, they’re just going to spin more rhetoric and hyperbole, while doing nothing to relieve people’s immediate suffering.
I knew an ex-cop who prided themselves on their law-abiding character always and even with Stage 4 refused to avail of offered CBD and THC oil until the very last, having finally been assured by three doctors and several former colleagues that it was Ok. It brought the poor sufferer some immediate surcease in terms of enhanced appetite, sleep, and bowel movement, while remaining compos mentis, all of which the various “ethical” poisons, the morphine derivatives and analogues destroy.
I knew another, a chemist, who absolutely despised the morphine based drugs and synthetics, and managed their pain through THC and paracetamol almost to the last. Again, compos mentis until the final eight hours.
Cancer is cruel enough. We shouldn’t make it crueller yet thru kowtowing to Big Pharma.
Mr. Kenny, what authority do you have to say that the HPRA report/decision was biased?
The HPRA evaluated the current haul of scientific evidence on the medical use of cannabis and based their report on that.
What does ‘practical experience’ have to do with clinical trials and meta-analyses? It seems you don’t understand how the regulatory body for medicines is supposed to function.
Indeed, if practitioners did have experience with the drug’s use, they’d be more likely to be biased either way based on limited data rather than conclusive evidence.
@Malachi: There are hundreds if peer reviewed studies on Cannabis as an effective analgesic.If you bothered to look.Somehow though , methinks you did’nt.
@Ian Moloney: My apologies Ian but could you direct me to the section where I could find pointers on writing meaningful posts ? I so much want to meet your aporoval.
@Diarmuid Doran: which is why the expert panel look at meta analyses of ALL studies, examining the quality of the studies, balancing the efficacy and the safety to produce a risk benefit analysis that properly reflects the appropriate use of any given drug. The HPRA know what they’re doing.
@Pharmy: I’m sure they do.I’m sure none of them have been tainted by previous employer history.Pharmy , on foot of your knowledge , Ill completely change my viewpoint.Tell me , have you had that ” Pharmy ” account for long ?
Pull the other one chap , its wooden.
@Malachi: Is it necessary to prove it works. Lots of drugs don’t work for everybody. If it’s not working take em off it and try something else. It’s pretty non toxic, so what’s wrong with the California model. Anyone can get a medical cannabis card. I don’t hear about all the chaos and lawsuits against the state. Which you might expect if this was a dangerous insufficiently tested drug. Let people grow it and try it doe themselves with medical support if needed. Anyone that wants it now can already get it. And keep up the rigorous testing at the same time.
@Malachi: yet the HPRA are going to allow a new epilepsy drug to be licenced in ireland, can’t think of the name of it at the moment, which has serious side effects for children using it, including heart problems and personality changes.
@Pharmy: Dont give me the Ad Hominem crap pharmy.Im way too long in the tooth for your mischief believe me.My namecis there if you wish to speak to me with your real name.Ive nothing to hide , have you ?
@Malachi: I dont think it has to be done that way. See above for why not. What’s wrong with the California model? Do existing drugs work all the time from everybody. Some of our money is already being ‘ wasted ‘ on prescriptions that later have to be changed.
Yes but there should be ample scientific evidence a drug is more effective than placebo for a drug to be approved and paid for by the taxpayer.
I’d much rather we had prescription drugs on the market that are sometimes ineffective (but are proven to work through scientific scrutiny) than drugs like cannabis that do not have any such evidence base supporting their use (except for select conditions).
I am in favour of the legalisation of cannabis for recreational use – but its use as an approved medical product is quite a different matter.
@Diarmuid Doran: What is your standard of evidence? The HPRA reviewed all of the literature on cannabis analgesia and concluded that the evidence did not support its use for that purpose.
Indeed the report acknowledged that some evidence indicates that cannabis can be effective for analgesia, but if you’d read it, you’d have seen their reasoning for not approving cannabis for that purpose;
“The data generally suggested an improvement in pain associated with cannabis products. When these clinical trials are combined, the overall estimate of benefit is moderate and there is no effect on patient’s self reported quality of life. The symptoms of pain are subjective, and the majority of clinical trials that have been conducted have been shown to be subject to a moderate risk of bias (where repeated errors in data collection have led to incorrect estimates). These biases mean that the treatment effects that have been reported in clinical trials of cannabis for chronic pain should be viewed with caution, and that the evidence-base in terms of benefit remains uncertain. In addition, cannabis products were associated with a greater risk of side effects, including serious side effects, when compared to other pain medicines. No studies have evaluated the
long term safety of treatment with cannabis products. Current evidence suggests that larger more definitive clinical trials are needed. This approach is consistent with the views of pain specialists and medical professional bodies who have cited concern about the use of cannabis and cannabinoids in the management of chronic pain, in the absence of proven benefit to risk data.”
@Malachi: You’re annoying me.My standard of evidence if you really want to know Malachi is excruciating pain from Stage 4 Colon , Liver , Lung & Lymph cancer , terminal by the way. Does that satisfy you , you know all prik?
From the ‘food’ that we are being sold to the ‘medicine’ we are being prescribed we are being killed off by these corporations….cancer comes from the food we are eating….that is fact….
It’s not about Harris or Kenny or any of those puppets in the dail, it’s your huge multinational drug companies based in Ireland , employing 1000′s that tell the government of the day what they would like in law, no debating, end of !!!
Same reason Ireland has nearly highest price in Europe for all pharmaceuticals, follow the money !
@Cathal Flood: Correctamundo. But that just sounds too crazy, lefty, hippy, conspiracy theory ish for some people. And the mere thought of losing market share to a plant kicks the lobby into top gear. St. Johns wort comes to mind. Surprised I can still buy Echinacea over the counter.
Those who promoted this bill are either wilfully or negligently ignorant of the science and practice of medicine. There are easier ways to promote the availability of cannabinoids for medicinal use within existing legislation. The real agenda here is recreational use.
@Pharmy: The real story here is alcohol is far more problematic and is totes legal. Legalise cannabis, let people see if it works for them. If not no harm done. And yes people will have legal access to a much safer recreational drug too. What’s wrong with that. What is the benefit of prohibiting it? I could kill myself with Panadol a million times easier than do serious harm with cannabis. Unless I accidentally choke on my brownie or something.
@Pharmy: and btw, I very much doubt the child would be smoking it. It would probably be dispensed in an oil form or capsule form like any other medicine.
Someone has a vested interest in keeping it out and are dong a very good job of trying to blur the line between medicinal cannabis and recreational cannabis and confusing the issue. And before anybody decides to point out they are the same thing, I know they come from the same plant, it’s the purpose they are used for that differentiates them
Medicinal cannabis is needed to help control certain conditions…..it won’t ever cure them unfortunately. People who need medicinal cannabis don’t have a choice.
Recreational cannabis i don’t really give two hoots about. That is each individual personal decision to use or not.
@Pharmy: the Misuse of Drugs Act contains four Schedules or lists of active agents (drugs). Each Schedule has different levels of restriction on the prescription, sale, possession & use of the drugs listed. Over the years drugs have been listed, delisted & rescheduled. A Bill went through the Dail last year coming into effect this month which rescheduled a number of drugs. Why wasn’t cannabis or specific cannabinoids included, there is sufficient evidence to merit it. The TDs who put forward the ‘Medicinal Cannabis Bill’ should have been aware of this. Once rescheduled cannabinoids could be licensed like any other medicine.
@Pharmy: Medicines licensed in other countries could be recognised & sold here. Medicines licensed via the European system could automatically be sold here. Licensing is important because it ensures that every tablet / drop / spray contains what it is claims to contain. If this cannot be guaranteed then over or under dosing results. Doctors need to know how much they are prescribing for a patient in order to balance desired effects with side effects in a way that is suitable for that patient. This is especially true for children.
@Pharmy: To summarise: a Bill that would allow for the licensing of medicinal cannabinoids (at no additional cost to the tax payer) was passing through the Dail at the same time as TDs proposed a Bill with (purportedly) the same purpose, but with the addition of new & expensive monitoring systems. The new bill is in fact more similar to the licensing of recreational drugs (alcohol & tobacco) … and they both turned out so well.
Anyone pushing a Bill through the Dail should know this, which suggests wilful / negligent ignorance as previously stated. Negligent ignorance implies incompetence. Wilful ignorance implies another agenda. Take your pick.
Welcome to the great KUMAR spell temple where you can get solution to all your problems
Do you want to be rich, famous, wants prosperity in your business, want your ex back to you, want people to love you, success in your examination, win bets, want to see vision, you need promotion in Work, you need healing to all types of diseases and lot more just contact the great kumar and now by messaging me and your problems will be solved. CONTACT US ON ( kumarkomartemple@yahoo.com ) WhatsApp No:+2347085067098
Decriminalise this drug now, then all the elitist fannys will have to concede that it has enormous potential for a positive impact when legalised. Look, it is going to happen. You are withholding the inevitable Simon Harris. Your damage is not beyond repair, be on the right side of history.
Voices of opposition are regurgitating the big pharma line. You could probably work out who gets big pharma perks just by listening to their babble around dangers of driving, the reactions with other meds, language being used is not their own, especially when they stutter and urmmm their way through a statement they obviously didn’t write themselves. The professor from Galway did a superb job as did the doctor. If they use cannabis products for the illnesses stated in the Barnes Report, big pharma will not be happy. Ireland has kissed the ass of big pharma, and been allowed free reign. People are not so naive, this is 21st century, and we have a voice.
Medical cannabis is available on prescription now in Canada – along with many other countries. An ageing and increasingly frail Leonard Cohen made use of it successfully to help him with severe pain during his last months. He was able to continue living in his home and recording songs until he passed on. If it’s good enough for Leonard it’s good enough for me.
FSAI orders recall of another two spinach products affected by Listeria monocytogenes
2 hrs ago
9.3k
16
Paul Gallagher
Older brother of Oasis members Noel and Liam Gallagher charged with rape
58 mins ago
7.2k
Listeria
Various branded spinach and mixed leaves recalled due to detection of listeria
Updated
23 hrs ago
86.4k
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 214 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage . Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework. The choices you make regarding the purposes and vendors listed in this notice are saved and stored locally on your device for a maximum duration of 1 year.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Social Media Cookies
These cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 149 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 195 partners can use this purpose
Use limited data to select advertising 158 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 119 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 120 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 51 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 48 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 177 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 78 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 111 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 116 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 51 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 65 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 36 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 122 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 126 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 94 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 67 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 116 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 103 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say